Skip to main content

and
  1. No Access

    Article

    Branched-chain amino acid catabolism in muscle affects systemic BCAA levels but not insulin resistance

    Elevated levels of plasma branched-chain amino acids (BCAAs) have been associated with insulin resistance and type 2 diabetes since the 1960s. Pharmacological activation of branched-chain α-ketoacid dehydrogen...

    Megan C. Blair, Michael D. Neinast, Cholsoon Jang, Qingwei Chu in Nature Metabolism (2023)

  2. No Access

    Article

    The Interface Microstructure and Mechanical Properties of Niobium-316L Stainless Steel Explosively Welded Composite Plate

    In order to manufacture stainless steel helium vessels for the superconducting radio frequency (SRF) cavities, niobium-316L stainless steel composite plates were fabricated by explosive welding technique. The ...

    Ruoxu Wang, Teng Tan, Yuan He, Yulu Huang in Journal of Materials Engineering and Perfo… (2020)

  3. No Access

    Article

    Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion

    Genetic deletion of HDAC3, a circadian epigenome regulator, specifically in skeletal muscle alters amino acid metabolism, leading to increased muscle endurance but at the cost of whole-body insulin resistance.

    Sungguan Hong, Wenjun Zhou, Bin Fang, Wenyun Lu, Emanuele Loro in Nature Medicine (2017)

  4. No Access

    Article

    A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance

    Fatty acid transport from blood vessels to skeletal muscle, across endothelial cells, is regulated by the branched chain amino acid metabolite 3-hydroxy-isobutyrate. This finding provides a mechanistic explana...

    Cholsoon Jang, Sungwhan F Oh, Shogo Wada, Glenn C Rowe, Laura Liu in Nature Medicine (2016)

  5. No Access

    Article

    Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo

    Insulin signalling and nutrient levels coordinate the metabolic response to feeding in the liver. Insulin signals in hepatocytes to activate Akt, which inhibits Foxo1 suppressing hepatic glucose production (HG...

    Paul M. Titchenell, Qingwei Chu, Bobby R. Monks in Nature Communications (2015)

  6. Article

    The role of mouse Akt2 in insulin-dependent suppression of adipocyte lipolysis in vivo

    The release of fatty acids from adipocytes, i.e. lipolysis, is maintained under tight control, primarily by the opposing actions of catecholamines and insulin. A widely accepted model is that insulin antagonis...

    Shlomit Koren, Lisa M. DiPilato, Matthew J. Emmett, Abigail L. Shearin in Diabetologia (2015)

  7. No Access

    Article

    Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

    Biguanides such as metformin, which is the most widely prescribed drug for type-2 diabetes, are shown to antagonize the actions of glucagon by decreasing the levels of cyclic AMP.

    Russell A. Miller, Qingwei Chu, Jianxin **e, Marc Foretz, Benoit Viollet in Nature (2013)

  8. No Access

    Article

    Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1

    The insulin signaling pathway regulating glucose homeostasis that has been well accepted is insulin-to-insulin receptor-to-IRS proteins-to-PI3K-to-Akt-to-Foxo1—a pathway that does not respond properly in state...

    Mingjian Lu, Min Wan, Karla F Leavens, Qingwei Chu, Bobby R Monks in Nature Medicine (2012)